Prior Antiplatelet Therapy, Excluding Phosphodiesterase Inhibitor Is Associated with Poor Outcome in Patients with Spontaneous Intracerebral Haemorrhage

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Translational Stroke Research

• Publication date

  2019-08-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12975-019-00722-xPMID 31446619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial.

  2018cited by this paper
• Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage Outcomes

  2017cited by this paper
• Validation of a novel claims-based stroke severity index in patients with intracerebral hemorrhage

  2016cited by this paper
• Nationwide Population Science: Lessons From the Taiwan National Health Insurance Research Database.

  2015cited by this paper
• Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database.

  2015cited by this paper
• Clinical outcomes in traumatic brain injury patients on preinjury clopidogrel: A prospective analysis

  2014cited by this paper
• Impact of Aspirin and Clopidogrel Interruption on Platelet Function in Patients Undergoing Major Vascular Surgery

  2014cited by this paper
• Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study

  2013cited by this paper
• Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants.

  2012cited by this paper
• Anti-platelet therapy: phosphodiesterase inhibitors.

  2011cited by this paper
• An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

  2011cited by this paper
• Validation of the national health insurance research database with ischemic stroke cases in Taiwan

  2011cited by this paper
• Prior antiplatelet therapy and outcome following intracerebral hemorrhage: A systematic review

  2011cited by this paper
• PRIOR ANTIPLATELET USE DOES NOT AFFECT HEMORRHAGE GROWTH OR OUTCOME AFTER ICH 2

  2010cited by this paper
• Prior antiplatelet therapy and outcome following intracerebral hemorrhage

  2010cited by this paper
• Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies

  2010cited by this paper
• Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.

  2010cited by this paper
• Prior antiplatelet therapy and outcome following intracerebral hemorrhage A systematic review

  2010cited by this paper
• Adenosine and Stroke: Maximizing the Therapeutic Potential of Adenosine as a Prophylactic and Acute Neuroprotectant

  2009cited by this paper
• Reduced Platelet Activity Is Associated With Early Clot Growth and Worse 3-Month Outcome After Intracerebral Hemorrhage

  2009cited by this paper
• Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH

  2009cited by this paper
• Reduced Platelet Activity is More Common than Reported Anti-Platelet Medication Use in Patients with Intracerebral Hemorrhage

  2009cited by this paper
• The effects of clopidogrel on elderly traumatic brain injured patients.

  2008cited by this paper
• Regular Aspirin-Use Preceding the Onset of Primary Intracerebral Hemorrhage is an Independent Predictor for Death

  2006cited by this paper
• Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage

  2005cited by this paper
• A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research.

  2005cited by this paper
• Previous antiplatelet therapy is an independent predictor of 30–day mortality after spontaneous supratentorial intracerebral hemorrhage

  2005cited by this paper
• Safety and Feasibility of Recombinant Factor VIIa for Acute Intracerebral Hemorrhage

  2005cited by this paper
• Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding.

  2005cited by this paper
• Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.

  2004cited by this paper
• The mechanism of action of aspirin.

  2003cited by this paper
• Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.

  1992cited by this paper

• Association Between Prior Antiplatelet Therapy and Prognosis in Patients With Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis.

  2024cites this paper
• Early Antiplatelet Resumption and the Risks of Major Bleeding After Intracerebral Hemorrhage

  2023cites this paper
• Transient Receptor Potential Mucolipin-1 Participates in Intracerebral Hemorrhage-Induced Secondary Brain Injury by Inducing Neuroinflammation and Neuronal Cell Death

  2023cites this paper
• Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage

  2023cites this paper
• Neurovascular Units and Neural-Glia Networks in Intracerebral Hemorrhage: from Mechanisms to Translation

  2021cites this paper
• Prior Antithrombotic Therapy is Associated with Increased Risk of Death in Patients with Intracerebral Hemorrhage: Findings from the Chinese Stroke Center Alliance (CSCA) Study

  2021cites this paper
• Effects of Prior Antiplatelet Therapy on Mortality, Functional Outcome, and Hematoma Expansion in Intracerebral Hemorrhage: An Updated Systematic Review and Meta-Analysis of Cohort Studies

  2021cites this paper
• Miro1 Regulates Neuronal Mitochondrial Transport and Distribution to Alleviate Neuronal Damage in Secondary Brain Injury After Intracerebral Hemorrhage in Rats

  2020cites this paper